• Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

  • Nov 5 2024
  • Length: 3 mins
  • Podcast

Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

  • Summary

  • Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.

    Show reference:

    https://journals.lww.com/neurotodayonline/pages/default.aspx

    https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.